483
Amplion Clinical Communications, Inc.FDA 483 - Amplion Clinical Communications, Inc. - September 08, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Amplion Clinical Communications, Inc. in Nashville, TN, a specification developer, revealed significant deficiencies in its quality system. Observations included inadequate procedures for corrective and preventive actions, complaint management, and documentation of design risk analysis. Additionally, the firm failed to adequately maintain its device master record for key components of its nurse call system.
Open in Dashboard
ID · 389d4dd7-6f9d-4e81-8575-4b9e65878dea